AstraZeneca CEO Pascal Soriot unpacks President Donald Trump's drug cost cut executive order on 'The Claman Countdown.' ...

A trial funded by AstraZeneca found the drug is effective in stopping cancer cells from using hormones to grow ...

All three major averages closed out May with sizable gains Friday, with the S&P 500 and Nasdaq Composite seeing their best ...

The primary endpoints of TROPION-Lung02 are dose-limiting toxicities and treatment-emergent adverse events. Secondary endpoints include ORR, DoR, PFS as assessed by investigator, overall survival, ...

AstraZeneca continues to impress me with the strong performances of its oncology, cardiovascular, and rare disease franchises ...

A Google Translate screenshot correctly shows that the name of the pharmaceutical company AstraZeneca, when written as “A stra ze neca,” means “a road to death” in Latin. We reached out to ...

Maryland governors will soon have to play by a new set of rules. On Tuesday, Gov. Wes Moore signed into law a bipartisan ...

The facility is part of AstraZeneca's $3.5 billion investment in U.S. research and manufacturing. Pope Leo XIV's voting history sparks speculation on political affiliation Rob Halford Explains Why ...

These investments have also included the expansion of AstraZeneca’s Global Research and Development (R&D) Hub and the creation of a new Alexion R&D Hub focused on rare disease research. With a 70-year ...

A warm welcome to AstraZeneca's first quarter 2025 Presentation ... the prevention of cardiovascular events in patients with a history of atherosclerotic cardiovascular disease and those at ...

EmblemHealth said in the lawsuit that AstraZeneca charges "one of the single highest drug costs in U.S. history" for Soliris, which costs "upwards of $500,000 per patient per year." AstraZeneca's ...